Table 4 Multivariable analysis of predictors of SLNB negative and/or, ALND negative lymph nodes among clinically T1-4 N1 patients who returned clinically N0 after neoadjuvant therapy (n = 150)
Parameters | Odds Ratio; 95%Cl | P value |
|---|---|---|
T stage T1-3 T4 | 8.75 (2.34–32.66) | 0.001 |
Pre-NAC lymph node, number <4 ≥4 | 4.92 (1.53–15.86) | 0.008 |
Histology Ductal Lobular | 1.82 (0.31–10.87) | 0.514 |
Post-operative Ki-67 Decrease in < 10% Stable/ increase/ or ≥ 10% | 5.11 (1.68–15.53) | 0.004 |
Luminal sub groups Luminal A/B Her-2 positive or Triple negative | 5,85 (1,59 − 21,39) | 0.008 |